Tissue BankingNCT06781411
Unity Cures Future (UCF) Biobank
An observational study of Tissue Banking, run by University of Central Florida at 1 site in United States.
Trial summary
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Tissue Banking
- How many people
- 10,000 participants
- Where
- 1 siteUnited States
- Study dates
- 6 Nov 2024to 6 Nov 2075
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Participants will donate unwanted human tissue as a result of surgery.
Who may be able to join
- be able to read and understand English
- scheduled for a surgery or procedure that will result in the removal of human tissue.
Who cannot join
- Pregnant
- unable to provide an informed consent
- unable to understand or read in English
- minors (ages under 18)
- prisoners
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Central Florida
Orlando, Florida, 32827
Britney-Ann Wray, BS, CTBS, CCRP, 4072668742, britney-ann.wray@ucf.edu
Amoy Fraser, PhD, CCRP, PMP, 4072668742, amoy.fraser@ucf.edu
About this study
Official title: Unity Cures Future (UCF) Biobank for Translational & Biomedical Research At UCF College of Medicine and Burnett School of Biomedical Sciences with Identifiable Human Tissue.
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Read the detailed description
The goal of this human tissue repository protocol is to aggregate resources and streamline the acquisition of human tissue. It is optimal for the advancement of biomedical and translational medical research that the human tissue be received under one protocol by the College of Medicine's the Clinical \& Aerospace Health Research team and transferred to the COM/BSBS research scientists for laboratory testing.
This aggregation of efforts and resources through a human tissue repository protocol allows for:
- Improvements in biomedical and translational medical research by availability of viable human tissues.
- Reduced recruitment and enrollment burden on the Clinical \& Aerospace Health Research team and the participants via pooled recruitment. Further, participants will only need to provide one informed consent. Received human tissue may be used for multiple protocols.
- Improved data for analysis as participants will complete an online case report form containing basic demographic data; planned location and date of upcoming surgery or procedure; diagnosis; name of surgeon/doctor for the planned surgery or procedure; type of surgery or procedure; medical data; medical history; and surgery history.
- Conditions
- Tissue Banking
- Keywords
- tissue, donate, surgery, biobank
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Donated Human Tissue | This Project will receive discarded human tissue from consented participants. For the purposes of this project, human tissue is defined as any bodily material collected from a human person, including bone marrow, skin, tumors, etc., through a clinical procedure. The clinical procedure will done not be done solely for the purpose of this Project. Participants (donors) will prospectively provide informed consent, complete an online case report form, and donate the unwanted human tissue that results from their surgery/procedure. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Receipt of donated human tissue for research
The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.
Measured: 50 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jan 2025
- Study start6 Nov 2024
- Primary completion6 Nov 2075 (estimated)
- Study completion6 Nov 2075 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Tissue BankingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 10,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Central Florida
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06781411
- Sponsor's protocol ID
- STUDY00007256
- Status last verified
- Jan 2025
- First submitted
- 13 Jan 2025
- Last updated
- 17 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Unity Cures Future (UCF) Biobank for Translational & Biomedical Research At UCF College of Medicine and Burnett School of Biomedical Sciences with Identifiable Human Tissue.
- ClinicalTrials.gov ID
- NCT06781411
- Acronym / sponsor ID
- STUDY00007256
- Conditions
- Tissue Banking
- Keywords
- tissue, donate, surgery, biobank
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- University of Central FloridaUniversity, hospital or other
- Study start
- 6 Nov 2024 (actual)
- Primary completion
- 6 Nov 2075 (estimated)
- Study completion
- 6 Nov 2075 (estimated)
- First posted
- 17 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Detailed description
The goal of this human tissue repository protocol is to aggregate resources and streamline the acquisition of human tissue. It is optimal for the advancement of biomedical and translational medical research that the human tissue be received under one protocol by the College of Medicine's the Clinical \& Aerospace Health Research team and transferred to the COM/BSBS research scientists for laboratory testing.
This aggregation of efforts and resources through a human tissue repository protocol allows for:
- Improvements in biomedical and translational medical research by availability of viable human tissues.
- Reduced recruitment and enrollment burden on the Clinical \& Aerospace Health Research team and the participants via pooled recruitment. Further, participants will only need to provide one informed consent. Received human tissue may be used for multiple protocols.
- Improved data for analysis as participants will complete an online case report form containing basic demographic data; planned location and date of upcoming surgery or procedure; diagnosis; name of surgeon/doctor for the planned surgery or procedure; type of surgery or procedure; medical data; medical history; and surgery history.
Study design
- Observational model
- Other
- Time perspective
- Other
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Donated Human Tissue | – | –This Project will receive discarded human tissue from consented participants. For the purposes of this project, human tissue is defined as any bodily material collected from a human person, including bone marrow, skin, tumors, etc., through a clinical procedure. The clinical procedure will done not be done solely for the purpose of this Project. Participants (donors) will prospectively provide informed consent, complete an online case report form, and donate the unwanted human tissue that results from their surgery/procedure. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Participants will donate unwanted human tissue as a result of surgery.
Key inclusion criteria (2 listed)
- be able to read and understand English
- scheduled for a surgery or procedure that will result in the removal of human tissue.
Key exclusion criteria (5 listed)
- Pregnant
- unable to provide an informed consent
- unable to understand or read in English
- minors (ages under 18)
- prisoners
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Receipt of donated human tissue for research
Time frame: 50 years
The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology. Frequently, these studies require human tissue for testing of assays and devices.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jan 2025.
Related trials for Tissue Banking
RecruitingObservational study
Biospecimen Procurement for Head and Neck Disorders
Hearing Disorder, Oral Mucosal Disease
RecruitingObservational study
Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age
Benign Cysts Ovarian, Cystectomy
RecruitingObservational study
A Clinico-biological Database of Lung Cancers
Lung Cancer
Active, not recruitingObservational study
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Multiple Myeloma, Waldenstrom's Macroglobulinemia
RecruitingObservational study
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Tissue Banking, run by University of Central Florida at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Britney-Ann Wray, BS, CTBS, CCRP (4072668742, britney-ann.wray@ucf.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Receipt of donated human tissue for research (time frame: 50 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2025.